Spondylodiscitis due to Clostridium ramosum infection in an immunocompetent elderly patient.

J Clin Microbiol

Laboratoire de Bactériologie, Virologie et Parasitologie, CHU Carémeau, and Institut National de la Santé et de la Recherche Médicale, Unité 431, Faculté de Médecine, 30029 Nîmes, France.

Published: May 2003

The first ever case of spondylodiscitis caused by Clostridium ramosum in an elderly immunocompetent patient has been reported. C. ramosum is usually an intestinal bacterium but may occasionally be isolated in clinical specimens as an opportunistic pathogen. This report shows that this anaerobic organism can cause bone tropism without there having been any contamination due to spinal surgery. The infection cleared after empirical therapy using intravenous amoxicillin and oral metronidazole.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC154680PMC
http://dx.doi.org/10.1128/JCM.41.5.2223-2226.2003DOI Listing

Publication Analysis

Top Keywords

clostridium ramosum
8
spondylodiscitis clostridium
4
ramosum infection
4
infection immunocompetent
4
immunocompetent elderly
4
elderly patient
4
patient case
4
case spondylodiscitis
4
spondylodiscitis caused
4
caused clostridium
4

Similar Publications

Hidradenitis Suppurativa from a Multi-Omic Scope.

J Cutan Med Surg

November 2024

Rheumatology Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain.

Article Synopsis
  • * Genetic studies have identified issues with Notch signaling and inflammasome function in HS, while syndromic HS is linked to mutations in certain autoinflammatory syndromes like PAPA and PASH.
  • * Research in proteomics and microbiome profiling highlights inflammatory pathways and a disturbed balance of bacteria in HS lesions, while metabolomic studies reveal imbalances in tryptophan and lipid metabolism, indicating potential bacterial involvement; however, establishing strong links across these
View Article and Find Full Text PDF

Effect of combined probiotics and doxycycline therapy on the gut-skin axis in rosacea.

mSystems

November 2024

Key Laboratory of Dairy Biotechnology and Engineering, Ministry of Education, Inner Mongolia Agricultural University, Hohhot, China.

Article Synopsis
  • Rosacea is a common skin condition characterized by redness, visible blood vessels, and acne-like symptoms, often treated with antibiotics, but extended use can lead to resistance and side effects.
  • This study explored the effects of probiotics combined with doxycycline treatment on rosacea, finding that probiotics improved skin conditions, decreased inflammation, and altered gut microbiota composition among participants.
  • Results indicated that the probiotic group experienced better skin health outcomes with reduced sebum and inflammation, as well as fewer antibiotic resistance genes compared to controls, supporting a connection between gut health and skin condition.
View Article and Find Full Text PDF
Article Synopsis
  • Clostridium ramosum is a rare and difficult-to-identify pathogen, primarily an anaerobic, spore-producing, gram-positive rod, which is generally not known to cause illness.
  • The case report discusses a 65-year-old immunocompromised man undergoing chemotherapy for follicular lymphoma who developed Clostridium ramosum bacteremia linked to aspiration pneumonia, presenting with fever, cough, and confusion.
  • Successful treatment involved intravenous piperacillin-tazobactam, and follow-up imaging showed resolution of lung issues, emphasizing the challenges in diagnosing and managing Clostridium ramosum infections in immunocompromised patients.
View Article and Find Full Text PDF
Article Synopsis
  • Increasing interest in microbiome therapies for ulcerative colitis (UC) highlights the need for better-targeted microbial interventions.
  • A study analyzed bacterial co-abundance groups (CAGs) using metagenomic data, finding specific bacterial groups associated with remission and active disease in UC patients.
  • Key microbial interactions, particularly within Lachnospiraceae, were identified as potential targets for microbiome-based treatments, with implications for designing future therapeutic strategies.
View Article and Find Full Text PDF

Gut microbiota from patients with Parkinson's disease causes motor deficits in honeybees.

Front Microbiol

July 2024

Microbiota Division, Department of Gastroenterology and Hepatology, First Medical Center, Chinese PLA General Hospital, Beijing, China.

Objective: Parkinson's disease (PD) is possibly caused by genetic factors, environmental factors, and gut microbiota dysbiosis. This study aims to explore whether the microbiota contributes to the behavior abnormalities of PD.

Methods: We transplanted gut microbiota from patients with PD or healthy controls (HC) into microbiota-free honeybees.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!